跳至主要内容
临床试验/CTRI/2026/03/105485
CTRI/2026/03/105485尚未招募不适用

A single arm clinical study to evaluate the combined effect of ashoka twaka ksheerpaka orally followed by ashoka ghruta uttarbasti in asrugdara [abnormal uterine bleeding (AUB)].

Dr. Snehal Zole1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

Abnormal uterine bleeding (AUB) is defined as any uterine bleeding that differs from the normal volume, duration, regularity, or frequency of the menstrual cycle. Nearly 17.9% of gynecological outpatient visits are due to AUB. It is categorized as blood loss greater than 80 ml, duration of bleeding more than 8 days, cycle length less than 24 days, or variation in cycle length equal to or greater than 10 days.

In Ayurveda, excessive excretion of Raja is termed Pradara and due to excessive discharge of Asruka it is known as Asrugdara. Because of the limitations of current medical and surgical treatments in modern medicine, there is a need to identify an effective, non surgical, and safe Ayurvedic therapy. Ayurvedic texts describe various treatment modalities for Asrugdara, among which Ashoka Twaka Ksheerpaka is selected for its Raktastambhaka, Garbhashaya Sankochaka, Vedanasthapaka, and Balya properties. Basti therapy is considered supreme in the management of Asrugdara.

The study was conducted by administering 50 ml of Ashoka Twaka Ksheerpaka orally twice daily from the fourth to the eighth day of menstruation, followed by 5 ml of Uttarbasti with Ashoka Ghrita once daily from the eighth to the twelfth day of menstruation for three consecutive menstrual cycles

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Subjects with classical symptoms of Asrugdara(AUB).
  • Subjects are in the age group of 20-50 yrs.
  • Subjects who are married.

排除标准

  • Subject having STD.
  • Subject having PID.
  • Subjects having Coagulopathic Disorder.
  • Subjects having CA cervix.

研究者

发起方
Dr. Snehal Zole
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Snehal Zole

Seth Govindaji Raoji Ayurved Mahavidyaly Solapur

研究点 (1)

Loading locations...

相似试验

Effect of Ashoka Twak Ksheerpak Taken Orally... | 临床试验